Maze Therapeutics, Inc. (MAZE)

Maze Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022
Debt / Equity Ratio	-0.28	-0.13	-0.11
Debt / EBITDA Ratio	-4.74	-0.50	-0.28
Debt / FCF Ratio	1.03	-0.57	-0.32
Quick Ratio	8.52	1.79	4.81
Return on Equity (ROE)	-19.41%	26.86%	40.69%
Return on Assets (ROA)	-	-140.43%	-76.65%
Return on Capital (ROIC)	-31.29%	30.40%	44.34%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).